A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

As health systems pursue scale, M&A could get bigger, more complex in 2018 and beyond

by Bryan Martin and Ion Skillrud, Deloitte & Touche LLP

Over the past several years, consolidation among hospitals and health systems has grown. Even more interesting than the number of mergers and acquisitions (M&A) are the sizes of the transactions, which also have increased. In 2018, we expect hospital and health system M&A trends will likely continue and that these transactions will become larger and more complex.

Read more

Beyond dollars and cents: Culture and communications are often keys to success in hospital M&A

by Chad Mulvany, Director, Healthcare Finance Policy, Strategy and Development, Healthcare Financial Management Association and Wendy Gerhardt, Senior Manager, Deloitte Center for Health Solutions, Deloitte Services LP

Hospital and health system executives tend to think about mergers and acquisitions (M&A) in terms of dollars and cents – the value of the deal, transaction dollars, performance, and future projections. But one area that is equally important in hospital M&A transactions – according to new research conducted by the Deloitte Center for Health Solutions and the Healthcare Financial Management Association (HFMA) – is culture and communications.

Read more

Is Dr. Smith in my network? MA enrollees want directories they can count on

by Danielle Moon, Specialist Leader, Deloitte Consulting LLP

During the early part of the decade, I was at the US Center for Medicare and Medicaid Services (CMS) where I headed a group that oversaw the Medicare Advantage (MA) program. At the time, MA provider directories really weren’t on our radar. But these electronic directories have come under scrutiny recently, and CMS is now conducting audits to help ensure the information is up to date and correct.

Read more

By 2025, costs, regs, changing payer mix will help drive innovative partnerships

by James Whisler, Principal, Deloitte Consulting LLP

The health care system is on the cusp of rapid change, which is being driven largely by health care affordability issues. The prohibitive cost of health insurance is causing access issues, and continued large premium increases are likely unsustainable. The premiums are expensive because the medical costs are expensive. And along with higher premiums, out-of-pocket costs for consumers have climbed to historic highs.

Read more

To ensure low-cost generic drugs, manufacturers must find equilibrium

by Faith Glazier, Principal, Deloitte Consulting LLP

Headlines and politics have been focusing quite a bit of attention on the price of pharmaceuticals – particularly generic drugs. While manufacturers of generic drugs have been effective at keeping treatment costs down, pressure to trim costs further could have the opposite effect, particularly if it leads to unprofitable products.

Generics account for the vast majority of drug sales in the US,

Read more

Hospital M&A can quickly boost scale, but deals often include unexpected costs

by Bryan Martin and Ion Skillrud, Deloitte & Touche LLP

Scale is often the primary motivation behind merger and acquisition (M&A) activities. Among many hospitals, M&A has been growing steadily over the past decade as health systems work to build scale and enter new markets. But unexpected costs and challenges often surface after such transactions conclude.

That was one of the key takeaways from a recent convening session with financial executives involved in hospital deals.

Read more